The receptor for advanced glycation endproduct (RAGE) is involved in diabetic complications and chronic inflammation, conditions known to affect the sensitivity towards apoptosis. Here, we studied the effect of genetically depleting RAGE on the susceptibility towards apoptosis. In murine osteoblastic cells, RAGE knockout increased both spontaneous and induced apoptosis. Decreased levels of B-cell lymphoma 2 protein and increased intrinsic apoptosis were observed in Rage À / À cells. Furthermore, loss of RAGE increased expression of the death receptor CD95 (Fas, Apo-1), CD95-dependent caspase activation and extrinsic apoptosis, whereas NF-kB-p65 nuclear translocation was diminished. Importantly, depletion of RAGE reduced the ubiquitination and degradation of p53 and p73 and increased their nuclear translocation. The increase of p53 and p73 transactivational activity was essential for the RAGE-dependent regulation of apoptosis, because knockdown of p53 and p73 significantly decreased apoptosis in RAGE-deficient but not in RAGE-expressing cells. Thus, the RAGE-mediated posttranslational regulation of p53 and p73 orchestrates a sequence of events culminating in control of intrinsic and extrinsic apoptosis signaling pathways.
INTRODUCTION
The receptor for advanced glycation endproduct (RAGE) is a signal-transducing pattern-recognition receptor of the immunoglobulin superfamily. [1] [2] [3] RAGE is highly expressed during embryonic development, whereas RAGE expression is generally low in most adult tissues and its physiological role in the absence of cellular stresses is incompletely understood. 3 RAGE has been recognized to possess a central role in the modulation of the innate immune response. 4 The pathophysiological relevance of enhanced RAGE signaling has been demonstrated in various acute and chronic inflammatory diseases including sepsis, diabetes and diabetic complications, cardiovascular disease and osteoporosis. [4] [5] [6] [7] [8] [9] [10] All these conditions are known to affect the regenerative potential and the sensitivity towards apoptosis. Ligation of RAGE can drive a cell into fundamentally different directions, promoting either survival or cell death. Sustained activation and upregulation of RAGE has been described to enhance survival. 11, 12 The survival pathways triggered by RAGE signaling include induction of autophagy and inhibition of apoptosis and necrosis. 10, 13, 14 But in other models, the ligation of RAGE induced apoptosis through mitogen-activated protein kinase signaling-for example, via extracellular signal-regulated protein kinase-1 and -2 (ERK-1 and -2)-, the generation of reactive oxygen species and NF-kB-dependent regulation of B-cell lymphoma 2 (Bcl-2) protein family members, activating the intrinsic apoptosis pathway. 11, 12, [15] [16] [17] [18] The net effect of RAGE signaling on apoptosis is dependent on the type of cell affected, the amount of specific ligands available, the tissue-specific level of RAGE expression and the particular tissue homeostasis. In this context, Huttunen et al. 11 showed in vitro that high (micromolar) concentrations of the RAGE ligand S100B induced apoptosis in neuroblastoma cells in a reactive oxygen species-dependent manner, whereas low (nanomolar) concentrations induced trophic effects with reduced sensitivity towards apoptosis. Protection from apoptosis and the antiapoptotic effect of low-grade RAGE signaling could be explained by significantly increased levels of anti-apoptotic Bcl-2. This RAGEmediated protective effect of Bcl-2 is in accordance with the known regulation of a broad spectrum of pro-and anti-apoptotic genes of the Bcl-2 family by perpetuated NF-kB activation, favoring survival and proliferation in affected tissues. 10, 19 In bone, RAGE signaling contributes to the proliferation, maturation and activation of osteoclasts. Mice deficient for RAGE show defective bone resorption and an increased bone mineral density, 6, 20 indicating a central role for RAGE in osteoclast physiology. RAGE ligands are generated and accumulated in the bone matrix of diabetic patients. 21 Both type 1 and type 2 diabetes result in defective bone remodeling with consequently impaired structural quality and functionality of the bone microarchitecture. 22, 23 Concerning bone formation, mesenchymal stem cells appear to become exhausted during diabetes and lose their potential to differentiate into osteoblasts. 24 Furthermore, AGE binding to RAGE is capable of inducing apoptotic cell death in osteoblasts in vitro and in vivo, 15 suggesting that RAGE mediates osteoblast apoptosis dependent on ligand availability and intracellular signaling. However, because RAGE may not only convey death signals but also survival signals due to regulation of NF-kB, 25 one might speculate that loss of RAGE deprives affected cells of essential survival signals, eventually increasing the susceptibility towards apoptosis.
We conducted a study investigating the effect of genetically depleting RAGE on susceptibility towards apoptosis and the underlying molecular mechanisms of RAGE-mediated apoptosis regulation.
RESULTS

Increased rates of spontaneous apoptosis in Rage
À / À cells
In murine osteoblastic cells (MOC), significant differences in spontaneous apoptosis were first detected after 24 h of incubation.
The number of annexin-V-positive Rage À / À cells exceeded the wild-type (WT) level about two-fold (Figure 1a ). Subdiploid DNA content was increased about two-fold or higher in Rage À / À cells from 48 h onwards (Figure 1b) . Increased spontaneous apoptosis in the absence of specific ligands is suggestive for an increased activation of the intrinsic apoptosis signaling pathways. Indeed, Rage À / À MOC showed elevated numbers of cells with depolarized mitochondria, the relative increases were comparable to those for early and late spontaneous apoptosis (Figure 1c) . Because RAGE signaling has been reported to mediate enhanced cell survival via induction of autophagy, 14, 26 measurements of autophagic flux were conducted. Only very little LC3-II antigen could be detected in WT, which was lost in Rage À / À (Figure 1d ), reflecting the loss of autophagy in RAGE-depleted MOC. Given the very low level of LC3-II signal in WT, we suppose that a significant contribution to the observed differences in RAGE-mediated resistance to apoptosis is rather unlikely. The effects observed Figure 2a,  lanes 1 þ 2) . TAp63 was expressed in very low amounts and no clear difference between WT and Rage À / À was detectable. Importantly, staining intensities for TAp53 and TAp73 were also increased in the nuclear fraction of Rage À / À MOC (Figure 2a,  lanes 3 þ 4) . In accordance with the results obtained in the immunoblots, MOC transfected with a p53 reporter plasmid revealed the combined p53 family transactivational activity to be more than three times higher in Rage À / À compared with WT ( Figure 2b ). No significant differences in TAp53 or TAp73 mRNA expression were detected (Figure 2c ), suggesting a posttranslational regulation of p53 and p73 stability. Although a detailed evaluation of p53 half-life was not possible due to the low amount of p53 in this nonmalignant cell line, half-life of p73 was increased in Rage À / À cells (Supplementary Figure S2) . Compared with the total amounts of p53 and p73 immunoprecipitated (input signal), the ubiquitination of p53 was slightly reduced and the ubiquitination of p73 was markedly reduced in Rage À / À MOC (Figure 2d 
Sensitivity towards intrinsic apoptosis is increased in Rage
À / À cells Increases in p53/p73 activity and spontaneous intrinsic apoptosis are suggestive for changes in the balance of pro-and antiapoptotic factors regulating the stability of the mitochondrial membrane. Rage À / À MOC levels of the anti-apoptotic Bcl-2 protein were lower and levels of pro-apoptotic Bax were higher compared with the WT (Figure 3a) , whereas no significant differences could be detected for Bak and Bcl-xl (Supplementary Figure S3) . Treatment with the DNA cross-linking drug cisplatin resulted in a strong dose-and time-dependent increase of mitochondrial depolarization and specific apoptosis in Rage 
Expression of death receptor CD95 is increased in Rage
The expression of death receptors on the cellular surface is an important parameter affecting the sensitivity towards apoptosis. In MOC, no significant differences for tumor necrosis factor receptor and TNF-related apoptosis inducing ligand receptor expression were detected on WT and Rage À / À (Supplementary Figure S4) . Importantly, CD95 (Fas, Apo-1) cell-surface expression was found to be significantly increased in Rage À / À (Figures 4a and b) , which is in accordance with a report by Hiwatashi et al. 27 CD95 mRNA was upregulated to a similar extend as the cell-surface density (Figure 4c ), indicating that the increased CD95 surface density in Rage À / À MOC is, at least in part, caused by increased de novo synthesis of CD95. Chromatin immunoprecipitation (IP) was performed to define the contribution of individual members of the p53 family, the NF-kB family and specificity proteins 1 and 3 (Sp1 and Sp3) to the increased transcription of CD95 in Rage À / À . The p53-responsive element in exon 1 of the murine CD95 gene and two sections of the promoter (labeled Sp1 and C/EBPb site; Figure 4d ) were examined. Binding of p53 and especially p73 to the p53-responsive element was increased in Rage À / À compared with WT ( Figure 4e ). This is compatible with a substantial contribution of p53 and p73 to the upregulation of CD95 mRNA in Rage À / À MOC. Sp3, p50 and p65 bound to the Sp1 site in WT but not in Rage À / À (Figure 4f ), whereas binding of cRel was detected only in Rage À / À . Differential binding of Sp3 to the Sp core-binding site at position À 251 to À 258 is likely to be of functional significance because binding of Sp1 to a homologous element represses CD95 transcription in human lymphocytes. 28 Based on the high degree of homology between Sp1 and Sp3, Sp3 supposedly exhibited a similar effect on CD95 promoter regulation in our model and increased CD95 expression in Rage À / À MOC by (Figure 4g ), binding of cRel occurred only in the WT, whereas p50 and C/EBPb bound only in Rage À / À . In summary, the p53 family, the NF-kB subunits and Sp3 appear to contribute to the upregulation of CD95 gene expression in Rage À / À MOC.
Reduced activity of NF-kB and increased cleavage of caspases in
The response of NF-kB activation upon CD95 ligation-a key regulatory mechanism in death receptor signaling-was assessed by the nuclear localization of the NF-kB subunit p65. In the WT, nuclear p65 increased significantly after CD95 activation and returned to the baseline level after 48 h. In Rage À / À MOC, however, p65 increased to a lesser extent and was further reduced from 24 h onwards (Figure 5a ). The decreased NF-kB activation in Rage À / À MOC was confirmed by expression analysis of known NF-kB-p65-target genes such as Vcam. In WT cells, CD95 activation for up to 24 h resulted in a continuous upregulation of Vcam mRNA. In Rage À / À cells, the expression remained significantly lower than in WT cells at each time point tested (Supplementary Figure S5A) . CD95 activation upregulated RAGE expression in WT cells as well and remained undetectable in Rage À / À cells (Supplementary Figure S5B) .
The activation of key caspases was determined by detection of cleaved caspase antigens via Western blot (Supplementary Figure  S6A) and caspase enzymatic activity assay. In untreated MOC, caspase activity did not differ significantly between WT and Rage À / À (Figures 5b-d) . In WT cells, no relevant changes were detected during 24 h. In Rage À / À cells, CD95-associated caspases-8 and -2 (ref. 29) , as well as apoptosome-associated caspase-9, were markedly activated as early as 12 h after activation of CD95 (Figures 5b and c, Supplementary Figure S6B) . Accordingly, the activity of the effector caspase-3 in Rage À / À exceeded the WT activity about six-fold after 24 h (Figure 5d ). The broad-spectrum caspase inhibitor zVAD effectively blocked CD95-induced apoptosis in WT and Rage À / À MOC (Supplementary Figure S6C ) and the same was true for inhibition of the CD95-associated caspase-8 ( Figure 5e ). The effect of inhibiting caspase-9 was equal to caspase-8 inhibition in WT and almost equal to caspase-8 inhibition in Rage À / À (Figure 5e ), demonstrating that CD95-induced apoptosis in WT and Rage À / À MOC depended on the mitochondrial amplification loop. In summary, these data demonstrate a reduced activation of NF-kB-p65 accompanied by an upregulation of caspase cleavage in Rage À / À MOC.
Increased sensitivity towards CD95-mediated extrinsic apoptosis in Rage
The functional significance of differential CD95 expression, NF-kB activation and caspase cleavage was analyzed in a panel of time course experiments. In CD95-mediated apoptosis, both early and late apoptotic cells were about three-to five-fold more frequent in Rage À / À compared with WT MOC (Figures 6a and b) . In primary fibroblasts, the depletion of RAGE changed expression of CD95 and susceptibility towards apoptosis into the same direction, although less pronounced than in MOC (Supplementary Figure  S7) . Concerning intrinsic apoptosis, CD95 signaling evoked an intense increase of depolarized mitochondria in Rage À / À MOC, whereas only a minor increase was detected in WT cells (Figure 6c ). Because chemotherapy leads to a combined induction of the intrinsic and extrinsic apoptosis pathways, 30 we investigated a potential synergy between intrinsic and extrinsic apoptosis signaling in MOC. Indeed, a combination of cisplatin treatment and activation of CD95 further increased apoptosis in Rage À / À , whereas WT cells remained largely unaffected (Figure 6d ). But CD95 does not necessarily induce apoptosis, low signaling levels can confer pro-survival signals as well. Figures S8C þ D) . The contribution of individual p53 family members to CD95-mediated apoptosis was determined via isoform-specific knockdown. À / À MOC (J) at indicated time points after addition of cisplatin (7 mg/ml). Graph shows the percentage of cells with depolarized mitochondria. Experiments b and c were performed in triplicates each, data given as mean ± s.d., n ¼ 3. *Po0.0005 MANOVA, between subject effect, time points/dosages were considered as repeated measurements.
Although WT apoptosis was not significantly reduced, the number of apoptotic Rage À / À MOC was markedly reduced by knockdown of TAp53 ( À 46%), TAp63 ( À 22%) and TAp73 ( À 41%) (Figure 6f) , demonstrating a substantial functional relevance of the p53 family in Rage À / À MOC. Of note, the effects of p73 knockdown were comparable to those of p53, suggesting a prominent role for p73 in the setting of RAGE and apoptosis. Taken together, these data demonstrate that the reduced ubiquitination of p53/p73 in Rage À / À synergistically affects the p53 family-regulated intrinsic and extrinsic apoptosis signaling pathways.
DISCUSSION
The current study demonstrates that genetic depletion of RAGE in nonmalignant cells interferes with the ubiquitination and degradation of p53 and p73. In combination with reduced NF-kB activation, the increase in p53 and p73 transactivational activity results in regulation of Bcl-2 family members and especially CD95 expression. The upregulation of spontaneous as well as induced intrinsic and extrinsic apoptosis demonstrate the fundamental impact of RAGE depletion on sensitivity towards apoptosis in nonmalignant cells.
It is well established that, in cancer cell lines, inhibition of apoptosis by RAGE involves (up)regulation of p53 (ref. 14) . In this respect, our data concerning p53/p73 ubiquitination provide a mechanistic explanation that leads towards a concept of RAGEdependent regulation of posttranscriptional modification in the absence of external ligands. This novel concept supports RAGE's role as a central player in the complex regulation of physiological functions in nonmalignant or dysregulated cells, extended from inflammation to regulation of quality control and apoptosis. We provide novel evidence on how RAGE modulates cell survival via p53 family regulation and reveal p73 to be a hitherto unrecognized factor in RAGE-mediated inhibition of apoptosis. The functional importance of the inhibitory effect of RAGE on apoptosis, tumor development and progression was demonstrated by Gebhardt et al. 32 in a model of experimental tumorigenesis, where Rage À / À mice showed increased apoptosis in epidermal cells and a resistance to skin carcinogenesis. Therefore, the RAGE-p53/p73-dependent repression of apoptosis confers a substantial survival benefit to challenged, dysregulated cells still in the pre-malignant stage, ultimately promoting tumorigenesis.
In support of this line of argument, we observed a RAGEdependent regulation of Bcl-2 family members. NF-kB activation is compromised in RAGE-deficient cells and the NF-kB pathway is a potent positive regulator of Bcl-2, as well as a negative regulator of Bax expression, 25 whereas the increased activity of p53 in Rage À / À MOC generates the opposite effect. 33 Thus, the specific difference in Bcl-2 and Bax protein levels in RAGE-deficient cells The RAGE-dependent differences in NF-kB activation and CD95 expression are capable to affect susceptibility towards apoptosis as well. Besides CD95 cell-surface density and ligand availability, various intracellular factors modulate the threshold for induction of CD95-mediated apoptosis. Among these factors, the initial intensity and the persistency of NF-kB activation following receptor ligation is a key regulatory mechanism. 35, 36 Because activation of NF-kB is diminished in Rage À / À cells and RAGE induces NF-kB-driven anti-apoptotic gene expression, 4, 5, 19 the observed decrease in NF-kB-p65 activation in Rage À / À MOC is most likely to contribute to the increased sensitivity towards CD95-induced apoptosis. Furthermore, CD95 signaling intensities below the threshold of apoptosis confer pro-survival signals and these CD95 survival pathways partly overlap with known RAGE signaling pathways, namely mitogen-activated protein kinases ERK-1/2 and NF-kB. 31 Consistently, knockdown of CD95 significantly reduced apoptosis in Rage À / À MOC. Based on our in vitro data, we suppose that in vivo, a reduced cell-surface density of CD95 on RAGE-expressing cells not only inhibits apoptosis but also interferes with the recognition of transformed cells by natural killer cells and cytotoxic T cells, further impairing the immunological elimination of genetically unstable, cancerprone or malignant cells.
Previous studies in cancer cell lines reported that apoptosis induced by RAGE ligation involves accumulation and phosphorylation of p53 (refs 14, 26, 37) , we extend the current knowledge on RAGE-regulated apoptosis to nonmalignant cells, demonstrating that the RAGE-dependent posttranslational regulation of p53 and p73 orchestrates a sequence of events culminating in regulation of the intrinsic and extrinsic apoptosis signaling pathways.
MATERIALS AND METHODS Reagents
Cisplatin: Gry-Pharma (Kirchzarten, Germany), 1, 
Isolation and culture of primary murine osteoblasts
MOCs from femurs of WT and Rage À / À mice 38 were isolated and identified as osteoblastic cell populations on the basis of alkaline phosphatase activity as described previously. 30 Western blot Preparation of total protein lysates has been described previously. 30 To separate cytoplasmic and nuclear extracts, cells were washed with ice cold phosphate-buffered saline and incubated in buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM DDT and complete protease inhibitor (Roche, Mannheim, Germany)) for 15 min on ice. NP-40 was added to a final concentration of 0.5% prior to homogenization and centrifugation at 13 000 g for 30 s. The supernatant was collected and the remaining pellet was resuspended in buffer C (10 mM HEPES, pH 7.9, 400 mM NaCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM DDT and complete protease inhibitor (Roche)) for 20 min on ice. The resulting nuclear lysates were centrifuged at 13 000 g for 2 min and the supernatant was collected.
In all, 10 mg of total protein was resolved on 12% sodium dodecyl sulfate-polyacrylamide gels, transferred to a polyvinylidene-difluoride membrane and probed with respective antibodies.
Induction of apoptosis
To induce CD95-mediated apoptosis, cells were treated with CD95-activating hamster anti-mouse antibody clone Jo2 at a concentration of 1 mg/ml approximately 24-48 h after reaching confluence unless stated otherwise. For chemotherapy-induced apoptosis, growing cells were treated with 7 mg/ml cisplatin for 24, 48 and 72 h or for 24 h prior to induction of CD95-mediated apoptosis. CD95-mediated apoptosis in cisplatin-and small interfering RNA (siRNA)-pretreated cells was induced under addition of 10 mg/ml cycloheximide.
Dual luciferase assay
MOCs were cotransfected with a pGL3 luciferase reporter plasmid bearing a p53-responsive element, 28 construct CD95(I þ SV)-luc) and the renilla luciferase-expressing control vector phRL-SV40 (Roche) by electroporation (MicroPorator-mini MP-100; Digital BioTechnology, Seoul, Korea). Briefly, 1.5-2 Â 10 6 cells were harvested and electroporated for 60 ms with 1100 V, using 5 mg of reporter plasmid and 100 ng of control vector. Cell lysates were obtained using a passive lysis buffer. Luciferase activities were determined using the Roche dual luciferase assay kit and normalized for variations in transfection efficiency by renilla activity.
Detection of death receptor expression
Cell-surface expression of death receptors was assessed by flow cytometry as described previously. 41 Caspase activity assay and caspase inhibition Caspase fluorometric assays and caspase inhibition were performed as described. 41 Chromatin IP For chromatin IP, cells were grown to confluence. After 24-48 h, cells were fixed in 1% formalin in phosphate-buffered saline at 37 1C for 1 h, followed by addition of 0.5 M Glycin for 10 min. After fragmentation by sonication, chromatin was immunoprecipitated using equal amounts of respective Semiquantitative and real-time PCR cDNA was prepared as described. 42 Semiquantitative PCR was performed for the lowest number of cycles needed to detect amplicon bands in subsequent gel electrophoresis using the following primers: CD95 ( IP IP was performed using the Pierce Classic IP Kit from Thermo Fisher Scientific (Ulm, Germany). Immunoprecipitated p53 and p73 were resolved by electrophoresis, transferred to a polyvinylidene-difluoride membrane and probed with polyubiquitin antibodies.
siRNA-mediated knockdown
For siRNA-mediated downregulation of CD95 and the p53 family, the following ON-Targetplus SMARTpool (Dharmacon, Bonn, Germany) siRNAs were applied: L-045283-00-0005 for CD95, L-040642-00-005 for p53, L-040654-00-0005 for p63 and L-043871-00-0005 for p73 and D-001810-10-20 as control. MOCs were transfected at a concentration of 50 nM using Nanofectin siRNA (PAA, Pasching, Austria). Apoptosis was induced 72 h after transfection.
Statistical analysis
We applied analysis of variance or multivariate analysis of variance using the SAS software system (SAS Institute Inc., Cary, NC, USA).
